Transdermal Therapeutic Systems for the Treatment of Alzheimer's Disease: A Patent Review

CONCLUSION: TTSs are primarily effective for delivering small molecules. The use of absorption enhancers and irritation mitigators can be necessary to enhance the performance. The development of these technologies is essential for the convenience of patients and caregivers.PMID:37990896 | DOI:10.2174/0118715273275957231102044934

Source: CNS and Neurological Disorders Drug Targets - November 22, 2023 Category: Drugs & Pharmacology Authors: Let ícia Basso Silvia Cristina Fagundes Tatiana Staudt Karini da Rosa Elizane Langaro Hamid Omidian Charise Dallazem Bertol Source Type: research